Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.
about
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerHow Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?The strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor controlExperimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decouplingCancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs
P2860
Q27021839-6A2F4E48-E7D4-4C99-A215-CEABD9DFFEEBQ33710433-2ECCCF4E-FC97-4235-BE2A-D2D465F16E02Q33724224-07341822-2F85-4654-9F24-A6F3CDD6B2DEQ33882758-8EB1CDD0-7317-4B24-AF48-18053DC7C7FAQ35641491-D4D3B0CC-C71F-48A8-87A6-95B8706E86B9Q36363838-ACAB1331-D992-405E-BCFF-B3BE3CB888F0Q39212798-90E56070-A308-4423-8820-AC6992F0BE34Q52688581-15BD35AF-5388-440E-9253-B402DF980146Q54378300-29258965-087C-40F5-8A99-FDA8F977319CQ57004644-99340D74-9631-4F47-8432-21FAC1F98E51
P2860
Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@ast
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@en
type
label
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@ast
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@en
prefLabel
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@ast
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@en
P2093
P2860
P356
P1433
P1476
Mutations in the glycoprotein ...... ial for oncolytic virotherapy.
@en
P2093
Alain Lamarre
Frédérick Brassard
Laurent Poliquin
Pascal Lapierre
Valérie Janelle
P2860
P304
P356
10.1128/JVI.02484-10
P407
P577
2011-05-11T00:00:00Z